Longwei Petroleum Investment Holding Ltd.
Symbol:
LPIH
Exchange:
OTCBB
Industry:
Services
Products:
Wholesale
Company Website:
Click Here
Company Info:
Click Here
Quote and News:
Click Here
Profiled Price:
$1.91 (November 20)
Company Snapshot:
Longwei Petroleum Investment Holding, Limited (the "Company") is an energy company that, through its subsidiaries, engages in oil and gas operations in the People's Republic of China ("PRC"). Oil and gas operations consist of transporting, marketing and selling finished petroleum products. The Company's headquarters and primary facilities are located in Taiyuan City, Shanxi Province ("Shanxi"). The Company's second facility is located in Gujiao, Shanxi. The Company purchases diesel, gasoline, fuel oil and kerosene (the "Products") from various petroleum refineries in the PRC. The Company is 1 of 3 licensed intermediaries in Taiyuan City and the sole licensed intermediary in Gujiao that operates its own large scale storage tanks. The Company has the necessary licenses to operate and sell Products not only in Shanxi but throughout the entire PRC. The Company's storage tanks have the largest storage capacity of any privately operated entity in Shanxi. The Company seeks to earn profits by selling its Products at competitive prices to large-scale gas stations, coal plants, other power-supply customers and small, independent gas stations. The Company also earns revenue by acting as a purchasing agent for other intermediaries in Shanxi and through the sale of diesel and gasoline at gas stations located at each of the Company's facilities.
|
|
Aradigm Corp.
Symbol:
ARDM
Exchange:
OTCBB
Industry:
Healthcare
Products:
Drugs
Company Website:
Click Here
Company Info:
Click Here
Quote and News:
Click Here
Profiled Price:
$0.16 (November 20)
Company Snapshot:
Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of a portfolio of drugs delivered by inhalation for the treatment of severe respiratory diseases by pulmonologists. The Company has product candidates addressing the treatment of cystic fibrosis, bronchiectasis, inhalation anthrax infections and smoking cessation.
|
